A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease (Q36467473)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease |
scientific article |
Statements
1 reference
A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease (English)
1 reference
Brenner MK
1 reference
Heslop HE
1 reference
Gottlieb DJ
1 reference
Bianchi AC
1 reference
Bello-Fernandez C
1 reference
Mehta AB
1 reference
Newland AC
1 reference
Galazka AR
1 reference
Scott EM
1 reference
Hoffbrand AV
1 reference
1 October 1989
1 reference
1 reference
610-615
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference